News | October 20, 2021
AstraZeneca India opens clinical data and insights division
The division is expected to grow to over a 100-member strong team by 2022
The division is expected to grow to over a 100-member strong team by 2022
Drugs and pharmaceuticals were among the top eight export items in H1FY22, according to a Care Ratings report.
It is the first presbyopia-correcting lens implant for cataract surgery
The first patient dosed with VX-880 demonstrated restoration of insulin production and achieved C-peptide of 560 pmol/L in response to Mixed Meal Tolerance Test (MMTT) at Day 90 visit
The trial met the primary endpoint of overall survival with a single priming dose of tremelimumab plus Imfinzi every four weeks vs. sorafenib
The capsules are indicated for the maintenance of normal sinus rhythm in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm
U.S. FDA to decide whether to authorize a booster dose in the coming days
The interim analysis showed that the MVC-COV1901 vaccine has a good safety profile and elicits promising neutralising antibody titres
U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma
New safety data show a consistent benefit-risk profile across all Ocrevus clinical trials
Subscribe To Our Newsletter & Stay Updated
